New Drugs 2020 : part 2 / Daniel A. Hussar

By:

Hussar, Daniel A

Series: Nursing 2020. 50 : 5, pages 31-40 Publication details: May 2020Content type:

text

Media type:

unmediated

Carrier type:

volume

Subject(s):

Amifampridine
Bremelanotide
Lefamulin
Rifamycin
Risakizumab-rzaa
Siponimod
Upadacitinib

Summary: This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.

Item type: Articles

Average rating: 0.0 (0 votes)

Holdings
Current library	Call number	Status	Date due	Barcode
Manila Tytana Colleges Library REFERENCE SECTION		Not for loan

This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.

Nursing.

There are no comments on this title.

to post a comment.

Print
Add to your cart (remove)
Suggest for purchase
Send to device
Save record
BIBTEX Dublin Core MARC (non-Unicode/MARC-8) MARCXML MODS (XML) RIS MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard)
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

New Drugs 2020 : part 2 / Daniel A. Hussar

Manila Tytana Colleges Library | Metropolitan Park, Pres. Diosdado Macapagal Blvd., Pasay City, 1300 Tel.(+63-2) 859-0826 | E-mail library@mtc.edu.ph

Manila Tytana Colleges Library | Metropolitan Park, Pres. Diosdado Macapagal Blvd., Pasay City, 1300
Tel.(+63-2) 859-0826 | E-mail library@mtc.edu.ph